MXPA02012907A - Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad. - Google Patents

Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.

Info

Publication number
MXPA02012907A
MXPA02012907A MXPA02012907A MXPA02012907A MXPA02012907A MX PA02012907 A MXPA02012907 A MX PA02012907A MX PA02012907 A MXPA02012907 A MX PA02012907A MX PA02012907 A MXPA02012907 A MX PA02012907A MX PA02012907 A MXPA02012907 A MX PA02012907A
Authority
MX
Mexico
Prior art keywords
prophylaxis
obesity
treatment
locating
compounds
Prior art date
Application number
MXPA02012907A
Other languages
English (en)
Spanish (es)
Inventor
Antel Jochen
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of MXPA02012907A publication Critical patent/MXPA02012907A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MXPA02012907A 2000-07-20 2001-07-12 Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad. MXPA02012907A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10035227A DE10035227A1 (de) 2000-07-20 2000-07-20 Verfahren zum Auffinden von Verbindungen, welche zur Behandlung und/oder Prophylaxe von Fettleibigkeit geeignet sind
PCT/EP2001/008051 WO2002007821A1 (de) 2000-07-20 2001-07-12 Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind

Publications (1)

Publication Number Publication Date
MXPA02012907A true MXPA02012907A (es) 2003-09-22

Family

ID=7649538

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02012907A MXPA02012907A (es) 2000-07-20 2001-07-12 Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.

Country Status (27)

Country Link
EP (1) EP1307262B1 (ru)
JP (1) JP2004504053A (ru)
KR (1) KR100818827B1 (ru)
CN (1) CN1443085B (ru)
AR (1) AR028730A1 (ru)
AT (1) ATE278441T1 (ru)
AU (2) AU2001277534B9 (ru)
BR (1) BR0112547A (ru)
CA (1) CA2416647A1 (ru)
CZ (1) CZ2003156A3 (ru)
DE (2) DE10035227A1 (ru)
DZ (1) DZ3393A1 (ru)
ES (1) ES2230346T3 (ru)
HK (1) HK1057499A1 (ru)
HU (1) HUP0302309A3 (ru)
IL (2) IL153971A0 (ru)
MX (1) MXPA02012907A (ru)
NO (1) NO20030233L (ru)
NZ (1) NZ523960A (ru)
PL (1) PL201165B1 (ru)
PT (1) PT1307262E (ru)
RU (1) RU2268721C2 (ru)
SK (1) SK287607B6 (ru)
TR (1) TR200402670T4 (ru)
TW (1) TWI274157B (ru)
UA (1) UA74588C2 (ru)
WO (1) WO2002007821A1 (ru)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1997370B (zh) 2004-05-19 2011-06-01 索尔瓦药物有限公司 N-氨磺酰-n＇-芳基哌嗪类化合物在制备用于预防或治疗肥胖和相关疾病的药物中的用途
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
KR20080012360A (ko) 2005-05-20 2008-02-11 얀센 파마슈티카 엔.브이. 설파미드 유도체의 제조 방법
AR057570A1 (es) 2005-11-14 2007-12-05 Solvay Pharm Gmbh Derivados de n-sulfamoil-n'-benzopiranopiperidinas espirocondensadas, composiciones farmaceuticas que los comprenden, un procedimiento para su preparacion y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por las isoenzimas anhidrasas carbonicas subtipos ii y/o
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
TW200812573A (en) 2006-05-19 2008-03-16 Janssen Pharmaceutica Nv Co-therapy for the treatment of epilepsy and related disorders
NO2106260T3 (ru) 2007-01-25 2018-05-05
US8809385B2 (en) 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
KR20150023405A (ko) * 2012-05-24 2015-03-05 베바 파마슈티칼스 엘티디 간 기능 개선 방법
CN106770611B (zh) * 2016-12-22 2019-01-29 广西师范大学 一种用于细胞原位检测小分子化合物进入线粒体的方法
RU2771430C1 (ru) * 2021-09-21 2022-05-04 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения антиконвульсантов в плазме крови больных эпилепсией

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552897A (en) * 1983-02-01 1985-11-12 American Cyanamid Company Salts of 1-(aminodihalophenyl)-2-aminoethanols and antilipogenic compositions prepared therefrom
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
JPH08502969A (ja) * 1992-10-29 1996-04-02 ジェネンテク，インコーポレイテッド 肥満の予防または治療方法
AU693478B2 (en) * 1994-11-10 1998-07-02 Metabolic Pharmaceuticals Limited Treatment of obesity
CA2258893C (en) * 1996-06-28 2005-06-14 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant sulfamate derivatives useful in treating obesity
US20030100594A1 (en) * 2001-08-10 2003-05-29 Pharmacia Corporation Carbonic anhydrase inhibitor

Also Published As

Publication number Publication date
HK1057499A1 (en) 2004-04-08
ATE278441T1 (de) 2004-10-15
RU2268721C2 (ru) 2006-01-27
PT1307262E (pt) 2004-12-31
EP1307262B1 (de) 2004-10-06
CN1443085A (zh) 2003-09-17
IL153971A (en) 2009-07-20
AU2001277534B9 (en) 2006-02-23
UA74588C2 (en) 2006-01-16
EP1307262A1 (de) 2003-05-07
AU7753401A (en) 2002-02-05
TWI274157B (en) 2007-02-21
CA2416647A1 (en) 2003-01-20
BR0112547A (pt) 2003-07-01
SK287607B6 (sk) 2011-03-04
IL153971A0 (en) 2003-07-31
KR100818827B1 (ko) 2008-04-01
AR028730A1 (es) 2003-05-21
HUP0302309A3 (en) 2005-06-28
PL201165B1 (pl) 2009-03-31
NO20030233D0 (no) 2003-01-17
NZ523960A (en) 2004-12-24
DE50104023D1 (de) 2004-11-11
DZ3393A1 (fr) 2002-01-31
SK612003A3 (en) 2003-06-03
AU2001277534B2 (en) 2005-09-29
WO2002007821A1 (de) 2002-01-31
NO20030233L (no) 2003-03-19
CN1443085B (zh) 2010-04-28
DE10035227A1 (de) 2002-01-31
PL363518A1 (en) 2004-11-29
KR20030022284A (ko) 2003-03-15
JP2004504053A (ja) 2004-02-12
HUP0302309A2 (hu) 2003-11-28
TR200402670T4 (tr) 2004-11-22
ES2230346T3 (es) 2005-05-01
CZ2003156A3 (cs) 2003-06-18

Similar Documents

Publication Publication Date Title
PL364995A1 (en) Method for the treatment or prevention of flavivirus
HK1062518A1 (en) Materials and methods for the treatment or prevention of obesity
MXPA03007960A (es) Compuestos y metodos para el tratamiento de desordenes urogenitales.
GB0512558D0 (en) Microorganisms for well treatment
MXPA02012907A (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.
HK1051690A1 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamidederivatives for the treatment of pain.
AU2001277534A1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
GB0129976D0 (en) Treatment method
EP1337255A4 (en) USE OF P38 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY COUGH
EP1442062A4 (en) METHOD FOR TREATING CARCINOMA
MXPA03001717A (es) METODO PARA EL TRATAMIENTO DE LA MIGRAnA.
AU2003263760A1 (en) Methods for the treatment or prevention of obesity
HK1064261A1 (en) Method for the treatment of tobacco.
AU2002364171A8 (en) Materials and methods for the treatment or prevention of obesity
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AP2004003070A0 (en) The method of treating cancer.
AU7750100A (en) Method for the treatment of obesity
GB0120147D0 (en) Treatment method
AU6137801A (en) Method and composition for the treatment of angiogenesis
MXPA03002280A (es) Proceso para purificacion de isooctano y/o diisobutileno.
ZA200101058B (en) Process for the treatment of gases.
SI1307262T1 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
ZA200007396B (en) Method of treatment.
AU2000272704A1 (en) Use of compounds for the treatment of obesity
GB0001861D0 (en) Method for the treatment of obesity

Legal Events

Date Code Title Description
FG Grant or registration